The largest database of trusted experimental protocols

Zr 75 1

Manufactured by Thermo Fisher Scientific
Sourced in United States

The ZR-75-1 is a laboratory instrument designed for in-vitro research purposes. It is a cell line derived from a breast carcinoma sample. The core function of the ZR-75-1 is to provide a standardized cell model for research applications.

Automatically generated - may contain errors

25 protocols using zr 75 1

1

Characterization of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The breast cancer cell lines ZR-75–1 and HCC1500 were purchased from American Type Culture Collection (ATCC). ZR-75–1 cells are homozygous variant for rs9940645, referred to as ZR-75–1 variant. ZR-75–1 cells that are homozygous wild-type for rs9940645, referred to as ZR-75–1 WT, were generated by CRISPR/Cas9 as previously described [7 (link)]. Hs578T breast cell line with ERα overexpression, referred to as Hs578T-ERα, was a generous gift from Thomas Spelsberg, Ph.D. (Mayo Clinic, Rochester, MN, USA). ZR-75–1 WT, ZR-75–1 variant, and HCC1500 were maintained in RPMI 1640 medium (Gibco) with 10% fetal bovine serum (FBS) (Atlanta Biologicals), while Hs578T-ERα was maintained in Dulbecco’s modified Eagle medium (DMEM) (Gibco) with 10% FBS. Lymphoblastoid cell lines (Coriell Cell Repository) with known genotypes for the ZNF423 SNP were transfected with ERα and maintained as previously described [6 (link), 7 (link)]. Only cell lines that are homozygous for the ZNF423 SNP were chosen.
+ Open protocol
+ Expand
2

Breast Cancer Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ZR-75-1 (ATCC #CRL-1500 pg, RRID: CVCL_0588), T-47D (HTB-133, RRID: CVCL_0553), and MDA-MB-453 (HTB-131, RRID: CVCL_0418) breast cancer cell lines were obtained from American Type Cell Culture Collection (ATCC; Manassas, VA, USA), and the MFM-223 cell line was obtained from the DMSZ-German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany, RRID: CVCL_1408). All cell lines were routinely tested for mycoplasma infection and authenticity confirmed by short tandem repeat profiling (Cell Bank Australia). ZR-75-1 and T-47D cells were maintained in RPMI-1640 medium (Invitrogen) containing 10% Fetal Bovine Serum (FBS) and 2 nM L-Glutamine (Sigma). MFM-223 cells were cultured in EMEM (Sigma) containing 10% FBS, 2 nM L-Glutamine (Sigma), 1 × Non-essential Amino Acids (Sigma), and 1 × Insulin–Transferrin–Sodium Selenite (Sigma). MDA-MB-453 cells were maintained in DMEM (Sigma) medium containing 10% FBS, 2 nM L-Glutamine (Sigma) and 1 × Sodium Pyruvate (Sigma). All lines were incubated at 37 °C and 5% CO2.
+ Open protocol
+ Expand
3

Transfection of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human breast cancer cell lines MDA-MB-231 (HTB-26), MCF7 (HTB-22), and ZR-75-1 (CRL-1500) were purchased from ATCC (Manassas, VA, USA) and cultured in a humidified cell culture chamber in RPMI (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal calf serum (Thermo Fisher Scientific) and Anti-Anti (Thermo Fisher Scientific), at 37 °C under a 5% CO2 atmosphere. Cultures were routinely checked for mycoplasma contamination using the EZ-PCR Mycoplasma Test kit (Biological Industries, Cromwell, CT, USA). Cultures were not used beyond 6 months after thawing. Al experiments were performed within 2 years after purchase of cell lines. For ASO transfection experiments, cells were seeded at 50,000 cells/well in a 12-well-plate (Nunc, Thermo Fisher Scientific). On the next day, cells were transfected with 200 nM (or 300 nM for ZR-75-1) ASO control (ASO-C: 5’-AGGTGGAGTGGATTGGGG) or Andes-1537 (5’-CACCCACCCAAGAACAGG) and 2 μg/ml Lipofectamine2000 (Invitrogen) or left untreated for 24 h. All ASOs contained 100% phosphorothioate internucleosidic bonds (Integrated DNA Technologies, Coralville, IA, USA). For mimic transfection, cells were seeded as above and transfected the next day with 0.5 nM control or specific mimic (Exiqon, Qiagen, Hilden, Germany) and 1 μg/ml Lipofectamine2000 (Thermo Fisher Scientific) and left for 48 h before processing.
+ Open protocol
+ Expand
4

Breast Cancer Cell Line Authentication and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
SK-BR-3, T47D, MDA-MB-468, and MDA-MB-157 cell lines were purchased and authenticated from the American Type Culture Collection (ATCC®, Manassas, VA, USA). MCF7, ZR-75-1, BT-20, HCC-1937, and MDA-MB-231 were purchased and authenticated from the Korean Cell Line Bank (KCLB®, Seoul, Republic of Korea). Human breast cancer cells were grown in DMEM (SK-BR-3, MDA-MB-157, MDA-MB-468, and Hs578T) or RPMI (MCF7, T47D, ZR-75-1, BT-20, HCC-1937, and MDA-MB-231) with 10% fetal bovine serum (FBS) (Gibco, Waltham, MA, USA) and 0.2% MycoZap™ Plus-CL (Lonza, Portsmouth, NH, USA) in a 37 °C humidified incubator with a 5% CO2 atmosphere. Cells were seeded on 10 cm dishes for RNAi transfection. Two ATP1A1 siRNAs and scrambled siRNA were purchased from Ambion and transfected into seeded cells using Lipofectamine RNAiMAX (Invitrogen, Waltham, MA, USA). For plasmid transfection, the ATP1A1 CDS was cloned into the pCMV-Tag2B vector and transfected into the cells using FuGene (Promega, Madison, WI, USA). Cells were harvested for further analysis and other experiments.
+ Open protocol
+ Expand
5

Breast Cancer Cell Line Culturing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BC cell lines ZR-75-1, MCF-7, T47D, BT474, HCC1937, MDA-MB-231, MDA-MB-435, MDA-MB-453, MDA-MB-468, and SKBR3 were purchased from American Type Culture Collection (ATCC). Dulbecco’s modified Eagle’s medium (DMEM) and RPMI 1640 (Gibco, CA, USA) with 10% foetal bovine serum (FBS) were used to culture MCF-7, MDA-MB-231, MDA-MB-435, MDA-MB-453, MDA-MB-468, SKBR3 and BT474, HCC1937, T47D, ZR-75-1 cells. The serum was purchased from Procell Life Science & Technology (Wuhan, China). All cells were cultured in a humidified incubator with 5% CO2 at 37 °C. The human BC and adjacent normal tissues used in this article were gifted by Dr. Bailin Zhang (National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) and were approved by the Institutional Review Board (IRB).
+ Open protocol
+ Expand
6

Cultivation and Maintenance of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 and ZR-75-1 were purchased from the American Type Culture Collection (ATCC) and were re-authenticated previously [29 (link)]. MCF-7 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco, Grand Island, NY, USA) supplemented with 1% penicillin–streptomycin (Gibco, USA) and 10 % fetal bovine serum (FBS) (Gibco, USA). ZR-75-1 cells were cultured in Improved Minimum Essential Medium (IMEM) (Gibco, USA) supplemented with 1% penicillin–streptomycin and 10% FBS. Epirubicin resistant MCF-7 cells (MCF-7 EpiR) and paclitaxel resistant MCF-7 cells (MCF-7 TaxR) were previously established by our group and were maintained in 10 µM epirubicin and 50 nM paclitaxel, respectively [32 (link)]. Stable BQ-overexpressed ZR-75 and its control ZR-75 EV cell lines were previously generated by our group using lentiviral system [29 (link)]. The cells were cultured in IMEM supplemented with 1% penicillin–streptomycin, 10 % FBS, and 5 µg/mL puromycin (Gibco, USA). The stable BQ-overexpressed MCF-7 cells were generated by transfecting pCDNA3.1-BQ-His (MCF-7 BQ) or pCDNA3.1-Empty (MCF-7 EV), followed by geneticin (Gibco, USA) selection. The stable cell lines were cultured in DMEM supplemented with 1% penicillin–streptomycin, 10 % FBS and 500 µg/mL geneticin.
+ Open protocol
+ Expand
7

Culturing Breast Cell Lines for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The normal breast cell line, MCF10A, and the human breast cancer cell lines, MDA-MB-231, HCC1937, ZR-75-1 and MCF7, were purchased from Cell Bank of the Chinese Academy of Science (Shanghai, China). MCF10A cells were cultured in mammary epithelial cell growth (MEGM) (Gibco BRL. Co. Ltd., Grand Island, NY, USA), MDA-MB-231 cells were cultured in L-15 medium (Gibco BRL. Co. Ltd.), HCC1937 and ZR-75-1 cells were cultured in RPMI 1640 (Gibco BRL. Co. Ltd.), MCF7 cells were cultured in minimum eagle medium (MEM) (Gibco BRL. Co. Ltd.), supplemented with FBS (Gibco BRL. Co. Ltd.) and 1% penicillin–streptomycin (Beyotime Biotech. Shanghai, China) in a humidified incubator at 37 ℃ with 5% CO2.
This study was approved by the Ethics Committee of Jinshan Hospital, Fudan University, Shanghai, China.
+ Open protocol
+ Expand
8

Characterization of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MCF-10A, MCF-7, ZR-75-1, BT-474, AU-565, SK-BR-3 and Hs578T cell lines were obtained from the American Type Culture Collection (ATCC). The T-47D, MDA-MB-468, BT-549 and MDA-MB-231 cell lines were obtained from NCI Development Therapeutics Program (DCTD Tumor Repository, National Cancer Institute at Frederick, MD). Stocks of frozen viable cells were generated immediately after one or two passages, and low passage number cells were used for all experiments. All cell lines were tested for mycoplasma infection with MycoSensor PCR Assay kit (Agilent Technologies) and only mycoplasma free cells were used for the experiments. The MCF-7, GCaMP2-MCF-7, SK-BR-3 and Hs578T cells were cultured in DMEM supplemented with 10% FBS (Gibco, Thermo Scientific), 100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM glutamine. The T-47D, ZR-75-1, BT-474, AU-565, MDA-MB-468, BT-549, MDA-MB-231 and GCaMP2-MDA-MB-231 cells were cultured in RPMI 1640 supplemented with 10% FBS (Gibco, Thermo Scientific), 100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM glutamine. The MCF-10A cell line was cultured in MEGM according to the instructions of ATCC. Cells were incubated at 37 °C and 5% CO2 in a humidified atmosphere.
+ Open protocol
+ Expand
9

Culturing ER+ and HER2- Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
ER+ breast cancer and HER2− cell lines MCF-7 and ZR-75-1 were purchased from American Type Culture Collection (Manassas, VA). MCF-7 is cultured in Dulbecco’s Modified Eagle Medium (41966-052, Gibco) supplemented with 10% of fetal bovine serum (10500-064, Gibco), and ZR-75-1 is cultured in RPMI-1640 medium (61870010, Gibco) supplemented with 10% FBS. MCF-7-PAX2 stable cell line is kept in additional 200 μg/ml of hygromycin B and 5 μg/ml puromycin.
+ Open protocol
+ Expand
10

Breast Cancer Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 cells were obtained from American Type Culture Collection (ATCC) (Manassas, VA, USA) and maintained and cultured in Dulbecco's modified Eagle's medium (DMEM) (Cellgro, Manassas, VA, USA) supplemented with 10% FCS and 1% penicillin/streptomycin (Cellgro) at 37°C incubator in 5% CO2 atmosphere. In addition, two ER+ (BT-474 and ZR-75-1) and two ER- (MDA-MB-468 and MDA-MB-231) cells obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) were also used in this study. BT-474 and ZR-75-1 were cultured in Gibco RPMI Media 1640 while MDA-MB-468 and MDA-MB-231 cells were cultured in Leibovitz's L-15 Medium. All of the complete mediums were supplemented with 10% FBS and 1% penicillin/streptomycin. BT-474 and ZR-75-1 cells were cultured at 37°C incubator in 5% CO2 atmosphere. MDA-MB-468 and MDA-MB-231 were cultured at 37°C incubator in a humidified atmosphere of 100% air.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!